FDA Authorizes First Point-of-Care Antibody Test for COVID-19
The U.S. Food and Drug Administration this week issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19.
Read MoreImmunology
Chester County Pharmaceutical Company Awarded Grant for COVID-19 Phase 2 Clinical Trial
EXTON, PA — Melior Pharmaceuticals (Melior) has been awarded a grant from the Commonwealth of Pennsylvania’s COVID-19 Vaccines, Treatments and Therapies (CV-VTT) Program, which is designed to support rapid advancement …
Read More
FDA Authorizes First Tests that Estimate a Patient’s Antibodies from Past SARS-CoV-2 Infection
The U.S. Food and Drug Administration recently authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual’s blood.
Read More
Exton’s Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
EXTON, PA — Immunome, a biotechnology company that harnesses the human B cell response to develop first-in-class therapeutics for oncology and infectious diseases, recently announced it has been awarded up …
Read More
Exton-based Megna Health Announces FDA EUA Approval of COVID-19 Antibody Combo Test Kit
EXTON, PA — Megna Health, a medical technology company focused on the development and manufacturing of diagnostic and healthcare products, announced recently that the Company has received Emergency Use Authorization …
Read More
FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
The U.S. Food and Drug Administration recently approved Tecartus (brexucabtagene autoleucel), a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded …
Read More
COVID-19 Antibody Testing Now Available at Tower Health Urgent Care
WEST READING, PA — Tower Health Urgent Care is now offering COVID-19 antibody testing. This test may help determine if an individual was exposed to the virus that causes COVID-19 …
Read More
Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release Syndrome in Hospitalized Patients with COVID-19
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates for immuno-inflammatory diseases, announced that the FDA has allowed an investigational …
Read More
Tower Health Participates in Plasma Donation Study with Mayo Clinic Program
WEST READING, PA — Tower Health announced that it is participating in important research involving the use of plasma from those who have recovered from COVID-19.
Read More
Chester County to Initiate COVID-19 Antibody Testing for Essential Service Individuals
WEST CHESTER, PA — The Chester County Commissioners and County health and emergency services officials announced today the County’s plan to undertake antibody testing of priority individuals who are currently …
Read More